Illustrative scenario · Healthcare
Governing clinical AI forpatient safety.
How a hospital or medical-technology provider could use Cytra to govern diagnostic AI against FDA 510(k) documentation requirements. Figures below are illustrative; this page does not represent a specific Cytra customer engagement.
Illustrative scenario — not a real customerThe challenge
Why clinical AI carries a heavier compliance load.
FDA regulatory compliance
Complex FDA 510(k) requirements for AI/ML medical devices with ongoing post-market surveillance obligations.
AI transparency for clinicians
Radiologists and physicians need explainable AI decisions to keep clinical oversight and patient trust.
Patient-safety monitoring
Continuous monitoring is required to catch performance degradation that could affect patient diagnoses.
Keep patient data out of AI payloads
Keep patient records out of AI-governance payloads; privacy obligations for that data stay with your own systems.
Common healthcare-AI pain points
- Manual compliance reviews
- Multi-month
- AI explainability
- Often partial
- Performance monitoring
- Manual / quarterly
- Model-change documentation
- Manual / ad hoc
Illustrative pain points — your real baseline will vary.
The Cytra approach
Healthcare-specific governance and safety monitoring.
Clinical decision support
Scheduled bias and performance measurement of diagnostic AI on eval datasets you configure.
- Model performance monitoring on eval datasets
- Bias measurement across eval cohorts
- Approval workflows for high-risk AI actions
FDA evidence
Evidence packages for FDA 510(k) assembled continuously from governed activity.
- Model-change and evaluation records
- Evidence packs from governed activity
- Access audit logs
AI explainability
Clinical-grade explanations for AI decisions with confidence intervals and uncertainty quantification.
- LIME / SHAP explanations
- Feature-importance views
- Uncertainty quantification
Implementation journey
A phased rollout, radiology first.
- 01
Clinical AI inventory (week 1–2)
Catalog clinical AI (radiology, pathology, decision support) and identify which fall under FDA 510(k) scope.
- 02
Pilot: radiology AI (week 3–8)
Deploy monitoring for chest-X-ray and CT diagnostic tools in a pilot unit, with clinician-facing explainability.
- 03
Hospital-wide deployment (week 9–16)
Extend coverage to remaining clinical AI with continuous FDA documentation.
Healthcare-specific features
Clinical integration, regulatory mapping.
Clinical integration
- EHR-adjacent AI governance
- Cytra does not integrate with EHR systems; no Epic or Cerner connector ships.
- Imaging AI model tracking
- Tracks radiology AI model versions, evaluation results and approvals.
- Clinical decision support
- AI-explainability views surfaced directly into physician workflows.
Regulatory compliance
- FDA 510(k) documentation
- Predicate-device comparisons and clinical-validation reports from governed activity.
- Access audit logging
- Every governed tool call logged with actor, scope and result. Not a HIPAA/PHI processing path.
- AI-governance review evidence
- Model inventory, evaluation and approval records for accreditation and AI-governance reviews; Cytra does not compute clinical quality measures.
Target outcomes
What the program is built to achieve.
- Fairness issues surfaced
- Earlier
- FDA audit prep effort
- Reduced
- Clinician explainability
- At decision time
- FDA evidence
- Continuous
Illustrative scenario — does not represent a specific customer. Outcomes depend on your clinical AI estate.
Sales-led, gateway by invitation
See this on your own clinical AI.
This is an illustrative scenario for evaluation only — it does not represent a specific Cytra customer. Tell us about your clinical AI estate and we will walk you through the platform.